Sponsored

Holista Colltech (ASX:HCT) ropes in new board member to fuel growth

Image Source: © Gajus | Megapixl.com

Summary

  • Biotech firm Holista Colltech has made significant board changes.
  • The Company has appointed Loren King as a non-executive director, holding a vast experience of 15 years in corporate finance and senior administration roles.
  • Current Executive Director and CEO, Dr Rajen Marnickavasagar has been appointed as Executive Chairman and CEO.

Holista Colltech Limited (ASX:HCT), a research-driven biotech company, has announced a new addition to its management resources. The Company has onboarded Loren King as a non-executive director, effective from 31 July 2021.

Headquartered in Australia, Holista is in the business of developing and commercialising food ingredients and ovine collagen for cosmetic and biomedical applications.

As the Company moves forward on its journey of growth, especially in the development of the collagen business based in Western Australia, Loren King is going to be a highly valuable asset for Holista.

Image source: Copyright © 2021 Kalkine Media

A glimpse of Loren King’s seasoned profile

Loren King holds a vast experience in corporate finance and senior administration roles. In the past 15 years, she has worked with several ASX-listed companies, stockbroking, and corporate advisory services.

She possesses highly valuable skillset in dealing with all aspects of corporate governance and compliance, specialising in initial public offerings (IPO), backdoor listings, private capital raising, and business development.

Ms King possesses a degree in Bachelor of Psychology and holds a Graduate Diploma in Applied Corporate Governance. She is a Fellow Member of the Governance Institute of Australia and holds a Certificate IV in Financial Services (Bookkeeping).

Other changes to HCT’s management team

Dr Rajen Manicka, the current Executive Director and CEO, has been appointed as Executive Chairman and CEO of the Company, with immediate effect. The development comes at a time when the Company had to let its Non-Executive Director and Chairman Daniel O Connor make an exit due to his retirement, effective 31 July 2021.

With a strengthened management team, Holista Colltech looks forward to making a robust progress in providing first-rate natural health-style products to its clients.

Premium quality ovine collagen 

Holista is the first company to produce ovine collagen from Australian sheep. It is a disease-free and culturally acceptable collagen source.

The collagen is widely used as a safe and natural biomaterial in the manufacture of cosmetic products. The Australian-produced collagen is regarded as an ideal substitute for Epidermal Growth Factor (EGF).

Holista’s collagen production facility in Western Australia uses a patent-protected technology.

The product is currently listed or authorised as ‘cosmetic grade’ in countries including Australia, New Zealand, Thailand, Malaysia, Singapore, Philippines, Vietnam, Taiwan, and the United States.

Stock information - HCT stock traded at AU$0.062 a share on 30 July 2021, with a market capitalisation of AU$17.07 million.


 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and